EPO and chronic kidney disease: At the same time, the in-depth investigation shed light on the mechanism of CKD-related anemia, giving more insight about anemia in ESRD patients being more than an “EPO deficient” status, but being an outcome of intricate interactions between the impaired production of EPO, chronic inflammatory status and disrupted iron balance (3).